Please login to the form below
Biogen expands digital safety platform Assessa
The MS technolgy pilot, a collaboration with Ixico, will now include pharmacoviglance reporting
Biogen has expanded work on its digital safety platform, which helps monitor MS patients for signs of the rare and potentially fatel brain infection progressive multifocal leukoencephalopathy (PML).
The pilot programme, a collaboration with tech firm Ixico, will now include pharmacoviglance reporting to monitor patients for previously unreported adverse reactions.
The partners - who have been in a collaborative agreement since October 2015 - developed the Assessa system to provide neurologists with second opinion reading services if there is a suspicion of PML.
Giulio Cerroni, chief executive officer of Ixico, said: “We are delighted to announce the expansion of this pilot involving clinical experts in specialist MS centres and Biogen.
“The Assessa PML digital platform is intended to provide technology and speciality services to physcians involved in delivering care to people living with MS.”
Biogen has invested £1.5m in the project, which is currently being piloted in five EU countries.
Share
Related Hub content
Featured jobs
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
Subscribe to our email news alerts
- Boehringer taps Korea’s Bridge for Ofev follow-up
- Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
- Novartis and J&J back latest €400m Medicxi biopharma fund
- How To Get To A Great Culture by Dave Birss
- Episode 2: Alder Play - Cameron Day (ustwo)
- Episode 1: Patient Centricity on Trial - Claire Knapp and Mark Evans, Havas Lynx Group, Keynote
PMHub
Dovetail
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
